Neurovisual Impairment: A Frequent Complication of Alpha-Interferon Treatment in Chronic Viral Hepatitis
Fig. 3. Visual field sensitivity in patients with normal baseline visual evoked responses who developed abnormally prolonged P100 latencies at the end of interferon therapy (inner line), contrasted with those who did not (outer line). Recordings represent average values of all involved eyes. Visual sensitivity was significantly suppressed in the former group of patients